Autologous Haematopoietic Stem Cell Transplantation for Japanese Patients with Systemic Sclerosis: Long-term Follow-up on a Phase II trial and Treatment-related Fatal Cardiomyopathy.

Nakamura Hiroyuki; Odani Toshio; Yasuda Shinsuke; Noguchi Atsushi; Fujieda Yuichiro; Kato Masaru; Oku Kenji; Bohgaki Toshiyuki; Sugita Junichi; Endo Tomoyuki; Teshima Takanori; Atsumi Tatsuya

doi:10.1080/14397595.2017.1416920

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

Autologous Haematopoietic Stem Cell Transplantation for Japanese Patients with Systemic Sclerosis: Long-term Follow-up on a Phase II trial and Treatment-related Fatal Cardiomyopathy.

作者：Nakamura Hiroyuki; Odani Toshio; Yasuda Shinsuke; Noguchi Atsushi; Fujieda Yuichiro; Kato Masaru; Oku Kenji; Bohgaki Toshiyuki; Sugita Junichi; Endo Tomoyuki; Teshima Takanori; Atsumi Tatsuya

来源：Modern Rheumatology, 2017, 28(5): 879-884.

DOI：10.1080/14397595.2017.1416920

摘要

To elucidate the efficacy and safety of autologous haematopoietic stem cell transplantation (HSCT) for Japanese patients with systemic sclerosis (SSc).;A phase II clinical trial included SSc patients diagnosed within the last three years having at least one of the following clinical features: diffu...